Doctors: Mylan lobbying feds to require EpiPen insurance coverage

Published



Mylan is trying to influence the government to make insurers fully cover its pricey EpiPen, a move that could ensure more people get the allergy shot but lead to higher costs elsewhere, a team of doctors say.

The Affordable Care Act requires insurers to cover preventive services without any co-pay, if those services get a top recommendation from the U.S. Preventive Services Task Force. The goal is to ensure that preventive services are covered, but a group of experts said the requirement is having the side effect of companies pushing the federal government to recommend unnecessary products.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.